Oramed Pharmaceuticals Statistics
NASDAQ: ORMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.37-0.01 (-0.23%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 4.37 0.00%
Oramed Pharmaceuticals by the numbers
Oramed Pharmaceuticals has a market capitalization of $181.8 million based on 41.60M shares outstanding. Its trailing P/E ratio is 1.1. The stock trades 5.8% below its 50-day average and 11.0% above its 200-day average.
Average daily trading volume is 194.57K shares, or about $850,284 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ORMP valuation vs. peer median
| Metric | ORMP | Peer median | Difference |
|---|---|---|---|
| Market cap | $181.78M | $182.15M | -0% |
| Avg. volume | 194.57K | 485.58K | -60% |
Peer median across 8 companies: ANTX, ADCT, CNTN, NGEN, ADAG, YARW, WHWK, ORGO.
Valuation
- Market cap
- $181.78M
- P/E (TTM)
- 1.06
- EPS (TTM)
- $4.13
- Shares outstanding
- 41.60M
Price and trading
- Previous close
- 4.38
- Open
- 4.35
- Day range
- 4.35 – 4.45
- 52-week range
- 2.09 – 5.47
- 52-week change
- +76.21%
- Beta
- —
- Volume
- 84.72K
- Average volume
- 194.57K
Dividends and events
- Annual dividend
- None
- Dividend yield
- 5.70%
- Next earnings date
- Aug 10, 2026
Additional statistics
- Market Cap
- 181.78M
- Pe
- 1.06
- Forward Pe
- -54.63
- Eps
- 4.13
- Dividend Yield
- 5.70%
- Dividend Rate
- 0.00
- Week52 High
- 5.47
- Week52 Low
- 2.09
- Avg Volume
- 194.57K
- Shares Outstanding
- 41.60M
- Ma50
- 4.64
- Ma200
- 3.94
- Earnings Date
- Aug 10, 2026
- Pct From52w High
- -20.11%
- Pct From52w Low
- 109.09%